Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Equazen eye q
- Development stage
- Unknown
- Lead developer
- SFI Health
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Small Molecules
- Administration
- Oral
01
Overview
Equazen eye q is a branded combination dietary supplement containing omega-3 and omega-6 essential fatty acids, specifically formulated to support brain development, concentration, learning ability, and healthy cognitive function in children and adults. The product contains a unique ratio of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and gamma-linolenic acid (GLA) at 9:3:1. EPA and DHA are sourced from high-quality fish oil (from mackerel, anchovies, sardines), while GLA is derived from evening primrose oil. The formulation has been clinically researched for its potential benefits in conditions such as attention-deficit/hyperactivity disorder (ADHD) and learning difficulties[1][2][3][4][5][6]. Mechanistically, these fatty acids are thought to play roles in neuronal membrane fluidity and neurotransmitter function.
- Brand names
- Equazen eye qEquazenEye Q
02
Targets
General cellular membrane phospholipids
Beyond the preview
Go deeper on Equazen eye q.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Equazen eye q.